Follow the Live #NephTrials Discussion on Spironolactone and its Impact on Dialysis Patients
Join the latest #NephTrials discussion on September 28, 2021, at 9 p.m. EST. The conversation will focus on Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease (ACHIEVE), which evaluates if spironolactone reduces heart failure and heart-related deaths in dialysis patients. The #NephTrials initiative is an exciting series of conversations combining expertise from the ISN-ACT...